Overactive Bladder - Results from #1900

Mirabegron: β3-adrenergic receptor agonist for the treatment of overactive bladder - Abstract June 21, 2013

Management of lower urinary tract dysfunction in multiple sclerosis: A systematic review and Turkish consensus report - Abstract June 21, 2013

Prospective and randomized comparison of electrical stimulation of the posterior tibial nerve versus oxybutynin versus their combination for treatment of women with overactive bladder syndrome - Abstract June 19, 2013

Psychometric performance of the Incontinence Quality-of-Life Questionnaire among patients with overactive bladder and urinary incontinence - Abstract June 19, 2013

Urinary ATP may be a dynamic biomarker of detrusor overactivity in women with overactive bladder syndrome - Abstract June 17, 2013

Lipid-based intravesical drug delivery systems with controlled release of trospium chloride for the urinary bladder - Abstract June 14, 2013

Neurogenic detrusor overactivity: An update on management options - Abstract June 13, 2013

Comparison between autonomic nervous system cardiovascular tests (ANSCVT) and lacrymal and or salivary secretion tests (LSST) in overactive bladder syndrome and voiding dysfunction - Abstract June 12, 2013

Analysis of female voiding dysfunction: A prospective, multi-center study - Abstract June 12, 2013

Intake of caffeinated, carbonated, or citrus beverage types and development of lower urinary tract symptoms in men and women - Abstract June 11, 2013

Meta-analysis of botulinum toxin a detrusor injections in the treatment of neurogenic detrusor overactivity following spinal cord injury - Abstract June 7, 2013

Reproducibility study of Overactive Bladder Symptom Score questionnaire and its response to treatment (RESORT) in Korean population with overactive bladder symptoms - Abstract June 6, 2013

First-line urological evaluation in multiple sclerosis: Validation of a specific decision-making algorithm - Abstract June 5, 2013

Mirabegron for the treatment of overactive bladder: A prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies - Abstract June 4, 2013

β3-receptor agonists for overactive bladder-new frontier or more of the same? - Abstract June 3, 2013

Lower urinary tract symptoms and falls risk among older women receiving home support: A prospective cohort study - Abstract May 31, 2013

Uroplasty announces positive coverage decision for percutaneous tibial nerve stimulation by Wisconsin Physicians Services May 31, 2013

The use of botulinum toxin for the treatment of overactive bladder syndrome - Abstract May 29, 2013

ICCS 2013 - Session Highlights: Intravesical drug delivery for OAB/urge incontinence May 29, 2013

ICCS 2013 - Session Highlights: Clinical insights in a percutaneous tibial nerve stimulation (PTNS) versus SHAM therapy for the treatment of overactive bladder syndrome (OAB) May 29, 2013

Page 96 of 122